These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 17273774)

  • 1. Doxorubicin transport by RALBP1 and ABCG2 in lung and breast cancer.
    Singhal SS; Singhal J; Nair MP; Lacko AG; Awasthi YC; Awasthi S
    Int J Oncol; 2007 Mar; 30(3):717-25. PubMed ID: 17273774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determinants of differential doxorubicin sensitivity between SCLC and NSCLC.
    Singhal SS; Wickramarachchi D; Singhal J; Yadav S; Awasthi YC; Awasthi S
    FEBS Lett; 2006 Apr; 580(9):2258-64. PubMed ID: 16579994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of RLIP76 in lung cancer doxorubicin resistance: II. Doxorubicin transport in lung cancer by RLIP76.
    Awasthi S; Singhal SS; Singhal J; Cheng J; Zimniak P; Awasthi YC
    Int J Oncol; 2003 Apr; 22(4):713-20. PubMed ID: 12632060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of PKCalpha and RLIP76 in transport-mediated doxorubicin-resistance in lung cancer.
    Singhal SS; Yadav S; Singhal J; Drake K; Awasthi YC; Awasthi S
    FEBS Lett; 2005 Aug; 579(21):4635-41. PubMed ID: 16087181
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Depletion of RLIP76 sensitizes lung cancer cells to doxorubicin.
    Singhal SS; Yadav S; Singhal J; Zajac E; Awasthi YC; Awasthi S
    Biochem Pharmacol; 2005 Aug; 70(3):481-8. PubMed ID: 15950949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of RLIP76 in lung cancer doxorubicin resistance: III. Anti-RLIP76 antibodies trigger apoptosis in lung cancer cells and synergistically increase doxorubicin cytotoxicity.
    Awasthi S; Singhal SS; Singhal J; Yang Y; Zimniak P; Awasthi YC
    Int J Oncol; 2003 Apr; 22(4):721-32. PubMed ID: 12632061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RLIP76 (RALBP1)-mediated transport of leukotriene C4 (LTC4) in cancer cells: implications in drug resistance.
    Sharma R; Singhal SS; Wickramarachchi D; Awasthi YC; Awasthi S
    Int J Cancer; 2004 Dec; 112(6):934-42. PubMed ID: 15386349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of RLIP76 in lung cancer doxorubicin resistance: I. The ATPase activity of RLIP76 correlates with doxorubicin and 4-hydroxynonenal resistance in lung cancer cells.
    Singhal SS; Singhal J; Sharma R; Singh SV; Zimniak P; Awasthi YC; Awasthi S
    Int J Oncol; 2003 Feb; 22(2):365-75. PubMed ID: 12527936
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regression of lung and colon cancer xenografts by depleting or inhibiting RLIP76 (Ral-binding protein 1).
    Singhal SS; Singhal J; Yadav S; Dwivedi S; Boor PJ; Awasthi YC; Awasthi S
    Cancer Res; 2007 May; 67(9):4382-9. PubMed ID: 17483352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RLIP76 transports vinorelbine and mediates drug resistance in non-small cell lung cancer.
    Stuckler D; Singhal J; Singhal SS; Yadav S; Awasthi YC; Awasthi S
    Cancer Res; 2005 Feb; 65(3):991-8. PubMed ID: 15705900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. POB1 over-expression inhibits RLIP76-mediated transport of glutathione-conjugates, drugs and promotes apoptosis.
    Yadav S; Zajac E; Singhal SS; Singhal J; Drake K; Awasthi YC; Awasthi S
    Biochem Biophys Res Commun; 2005 Mar; 328(4):1003-9. PubMed ID: 15707977
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The multidrug resistance transporter ABCG2 (breast cancer resistance protein 1) effluxes Hoechst 33342 and is overexpressed in hematopoietic stem cells.
    Kim M; Turnquist H; Jackson J; Sgagias M; Yan Y; Gong M; Dean M; Sharp JG; Cowan K
    Clin Cancer Res; 2002 Jan; 8(1):22-8. PubMed ID: 11801536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of ABCG2/BCRP Expression on Efflux and Uptake of Gefitinib in NSCLC Cell Lines.
    Galetti M; Petronini PG; Fumarola C; Cretella D; La Monica S; Bonelli M; Cavazzoni A; Saccani F; Caffarra C; Andreoli R; Mutti A; Tiseo M; Ardizzoni A; Alfieri RR
    PLoS One; 2015; 10(11):e0141795. PubMed ID: 26536031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ATP-dependent activity and mitochondrial localization of drug efflux pumps in doxorubicin-resistant breast cancer cells.
    Dartier J; Lemaitre E; Chourpa I; Goupille C; Servais S; Chevalier S; Mahéo K; Dumas JF
    Biochim Biophys Acta Gen Subj; 2017 May; 1861(5 Pt A):1075-1084. PubMed ID: 28214549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RLIP76 is the major ATP-dependent transporter of glutathione-conjugates and doxorubicin in human erythrocytes.
    Sharma R; Singhal SS; Cheng J; Yang Y; Sharma A; Zimniak P; Awasthi S; Awasthi YC
    Arch Biochem Biophys; 2001 Jul; 391(2):171-9. PubMed ID: 11437348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gefitinib ("Iressa", ZD1839), an epidermal growth factor receptor tyrosine kinase inhibitor, reverses breast cancer resistance protein/ABCG2-mediated drug resistance.
    Nakamura Y; Oka M; Soda H; Shiozawa K; Yoshikawa M; Itoh A; Ikegami Y; Tsurutani J; Nakatomi K; Kitazaki T; Doi S; Yoshida H; Kohno S
    Cancer Res; 2005 Feb; 65(4):1541-6. PubMed ID: 15735043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Celecoxib enhances doxorubicin-induced cytotoxicity in MDA-MB231 cells by NF-kappaB-mediated increase of intracellular doxorubicin accumulation.
    van Wijngaarden J; van Beek E; van Rossum G; van der Bent C; Hoekman K; van der Pluijm G; van der Pol MA; Broxterman HJ; van Hinsbergh VW; Löwik CW
    Eur J Cancer; 2007 Jan; 43(2):433-42. PubMed ID: 17097285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multidrug resistance mediated by the breast cancer resistance protein BCRP (ABCG2).
    Doyle L; Ross DD
    Oncogene; 2003 Oct; 22(47):7340-58. PubMed ID: 14576842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Regulation mechanism of breast cancer resistance protein by toremifene to reverse BCRP-mediated multidrug resistance in breast cancer cells].
    Zhang YH; Li G; Yu J; Xu MS; Liu ZX
    Zhonghua Zhong Liu Za Zhi; 2011 Sep; 33(9):654-60. PubMed ID: 22340044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sensitization of ABCG2-overexpressing cells to conventional chemotherapeutic agent by sunitinib was associated with inhibiting the function of ABCG2.
    Dai CL; Liang YJ; Wang YS; Tiwari AK; Yan YY; Wang F; Chen ZS; Tong XZ; Fu LW
    Cancer Lett; 2009 Jun; 279(1):74-83. PubMed ID: 19232821
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.